| Comprehensive molecular portraits of human breast tumours Cancer Genome Atlas Network Nature 490 (7418), 61-70, 2012 | 11688* | 2012 |
| Supervised risk predictor of breast cancer based on intrinsic subtypes JS Parker, M Mullins, MCU Cheang, S Leung, D Voduc, T Vickery, ... Journal of clinical oncology 27 (8), 1160-1167, 2009 | 5437 | 2009 |
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, J Matera, MC Miller, ... New England Journal of Medicine 351 (8), 781-791, 2004 | 5382 | 2004 |
| Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer MCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ... JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 2009 | 3218 | 2009 |
| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 2275 | 2018 |
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National Cancer Institute 103 (22), 1656-1664, 2011 | 2138 | 2011 |
| The molecular portraits of breast tumors are conserved across microarray platforms Z Hu, C Fan, DS Oh, JS Marron, X He, BF Qaqish, C Livasy, LA Carey, ... BMC genomics 7, 1-12, 2006 | 1925 | 2006 |
| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1675 | 2016 |
| Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1574 | 2015 |
| Proteogenomic characterization of human colon and rectal cancer B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ... Nature 513 (7518), 382-387, 2014 | 1483 | 2014 |
| Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1–and/or ErbB-2–positive, estrogen receptor–positive primary breast cancer: evidence from a … MJ Ellis, A Coop, B Singh, L Mauriac, A Llombert-Cussac, F Jänicke, ... Journal of Clinical Oncology 19 (18), 3808-3816, 2001 | 1465 | 2001 |
| Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer M Cristofanilli, DF Hayes, GT Budd, MJ Ellis, A Stopeck, JM Reuben, ... Journal of Clinical Oncology 23 (7), 1420-1430, 2005 | 1399 | 2005 |
| Genome remodelling in a basal-like breast cancer metastasis and xenograft LI Ding, MJ Ellis, S Li, DE Larson, K Chen, JW Wallis, CC Harris, ... Nature 464 (7291), 999-1005, 2010 | 1370 | 2010 |
| CDK4/6 inhibition triggers anti-tumour immunity S Goel, MJ DeCristo, AC Watt, H BrinJones, J Sceneay, BB Li, N Khan, ... Nature 548 (7668), 471-475, 2017 | 1327 | 2017 |
| Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival DF Hayes, M Cristofanilli, GT Budd, MJ Ellis, A Stopeck, MC Miller, ... Clinical Cancer Research 12 (14), 4218-4224, 2006 | 1242 | 2006 |
| Whole-genome analysis informs breast cancer response to aromatase inhibition MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ... Nature 486 (7403), 353-360, 2012 | 1234 | 2012 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 993 | 2016 |
| Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer GT Budd, M Cristofanilli, MJ Ellis, A Stopeck, E Borden, MC Miller, ... Clinical Cancer Research 12 (21), 6403-6409, 2006 | 991 | 2006 |
| Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study W Eiermann, S Paepke, J Appfelstaedt, A Llombart-Cussac, J Eremin, ... Annals of Oncology 12 (11), 1527-1532, 2001 | 954 | 2001 |
| A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer TO Nielsen, JS Parker, S Leung, D Voduc, M Ebbert, T Vickery, SR Davies, ... Clinical Cancer Research 16 (21), 5222-5232, 2010 | 934 | 2010 |
Torsten NielsenProfessor of Pathology, University of British ColumbiaZweryfikowany adres z mail.ubc.ca